ProShare Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,077
| Closed | -$934K | – | 2215 |
|
|
2025
Q1 | $934K | Buy |
7,077
+2,057
| +41% | +$271K | ﹤0.01% | 834 |
|
|
2024
Q4 | $419K | Sell |
5,020
-1,224
| -20% | -$102K | ﹤0.01% | 1386 |
|
|
2024
Q3 | $457K | Sell |
6,244
-13,721
| -69% | -$1M | ﹤0.01% | 1186 |
|
|
2024
Q2 | $1.37M | Sell |
19,965
-3,656
| -15% | -$250K | ﹤0.01% | 712 |
|
|
2024
Q1 | $1.63M | Buy |
23,621
+1,962
| +9% | +$136K | ﹤0.01% | 694 |
|
|
2023
Q4 | $1.55M | Buy |
21,659
+3,209
| +17% | +$230K | ﹤0.01% | 685 |
|
|
2023
Q3 | $961K | Buy |
18,450
+57
| +0.3% | +$2.97K | ﹤0.01% | 731 |
|
|
2023
Q2 | $1.16M | Buy |
18,393
+1,044
| +6% | +$66.1K | ﹤0.01% | 703 |
|
|
2023
Q1 | $939K | Sell |
17,349
-2,273
| -12% | -$123K | ﹤0.01% | 736 |
|
|
2022
Q4 | $1.04M | Buy |
19,622
+1,597
| +9% | +$84.5K | ﹤0.01% | 736 |
|
|
2022
Q3 | $840K | Buy |
18,025
+387
| +2% | +$18K | ﹤0.01% | 768 |
|
|
2022
Q2 | $1.01M | Sell |
17,638
-6,995
| -28% | -$399K | ﹤0.01% | 758 |
|
|
2022
Q1 | $1.51M | Sell |
24,633
-2,280
| -8% | -$139K | ﹤0.01% | 789 |
|
|
2021
Q4 | $1.41M | Buy |
26,913
+476
| +2% | +$24.9K | ﹤0.01% | 876 |
|
|
2021
Q3 | $986K | Sell |
26,437
-6,487
| -20% | -$242K | ﹤0.01% | 917 |
|
|
2021
Q2 | $1.34M | Buy |
32,924
+4,000
| +14% | +$163K | ﹤0.01% | 876 |
|
|
2021
Q1 | $981K | Buy |
28,924
+1,863
| +7% | +$63.2K | ﹤0.01% | 998 |
|
|
2020
Q4 | $861K | Buy |
27,061
+8,203
| +43% | +$261K | ﹤0.01% | 951 |
|
|
2020
Q3 | $484K | Buy |
18,858
+764
| +4% | +$19.6K | ﹤0.01% | 954 |
|
|
2020
Q2 | $464K | Buy |
18,094
+6,006
| +50% | +$154K | ﹤0.01% | 985 |
|
|
2020
Q1 | $186K | Sell |
12,088
-5,900
| -33% | -$90.8K | ﹤0.01% | 1023 |
|
|
2019
Q4 | $617K | Sell |
17,988
-2,022
| -10% | -$69.4K | ﹤0.01% | 972 |
|
|
2019
Q3 | $149K | Sell |
20,010
-825
| -4% | -$6.14K | ﹤0.01% | 1492 |
|
|
2019
Q2 | $270K | Sell |
20,835
-2,759
| -12% | -$35.8K | ﹤0.01% | 1301 |
|
|
2019
Q1 | $287K | Buy |
23,594
+318
| +1% | +$3.87K | ﹤0.01% | 1279 |
|
|
2018
Q4 | $265K | Sell |
23,276
-4,515
| -16% | -$51.4K | ﹤0.01% | 1217 |
|
|
2018
Q3 | $603K | Sell |
27,791
-1,093
| -4% | -$23.7K | ﹤0.01% | 1029 |
|
|
2018
Q2 | $510K | Sell |
28,884
-1,777
| -6% | -$31.4K | ﹤0.01% | 1110 |
|
|
2018
Q1 | $645K | Sell |
30,661
-5,044
| -14% | -$106K | ﹤0.01% | 997 |
|
|
2017
Q4 | $517K | Buy |
35,705
+8,929
| +33% | +$129K | ﹤0.01% | 1115 |
|
|
2017
Q3 | $423K | Buy |
26,776
+1,507
| +6% | +$23.8K | ﹤0.01% | 1028 |
|
|
2017
Q2 | $314K | Sell |
25,269
-1,776
| -7% | -$22.1K | ﹤0.01% | 1144 |
|
|
2017
Q1 | $439K | Sell |
27,045
-7,053
| -21% | -$114K | ﹤0.01% | 1052 |
|
|
2016
Q4 | $515K | Buy |
+34,098
| New | +$515K | 0.01% | 1059 |
|
|
2016
Q1 | – | Sell |
-3,881
| Closed | -$209K | – | 1658 |
|
|
2015
Q4 | $209K | Buy |
+3,881
| New | +$209K | ﹤0.01% | 1517 |
|